Although we did not find relationships between LEF1 gene expression and the clinical/pathological parameters of CRC patients, we were interested in evaluating the potential role of LEF1 as an early biomarker of colorectal carcinogenesis since its activation by MYC has been associated with the activation of the WNT pathway signaling. The gene discussed is MYC; the disease is colorectal carcinoma.